This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a Université Laval directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $2,626,763
Maternal Omega-3 supplementation to reduce Bronchopulmonary Dysplasia in very Preterm Infants : A Randomized Controlled Trial (MOBYDIck Trial)
CIHR · 2014 · Principal investigator
- $100,000
Maternal Omega-3 supplementation to reduce Bronchopulmonary Dysplasia in very Preterm Infants : A Randomized Controlled Trial (MOBYDIck Trial)
CIHR · 2013 · Principal investigator
Maternal Omega-3 supplementation to reduce Bronchopulmonary Dysplasia in very Preterm Infants : A Randomized Controlled Trial (MOBYDIck Trial)
Principal investigators: Marc, Isabelle; Fraser, William D; Lacaze-Masmonteil, Thierry; Lavoie, Pascal; Mâsse, Benoît R; Nuyt, Anne Monique
Keywords: Breastfeeding; Bronchopulmonary Dysplasia; Child Neurodevelopment; Neonatal Nutrition; Omega-3 Fatty Acids; Perinatality; Prematurity; Randomized Controlled Trial
Maternal Omega-3 supplementation to reduce Bronchopulmonary Dysplasia in very Preterm Infants : A Randomized Controlled Trial (MOBYDIck Trial)
Principal investigators: Marc, Isabelle; Fraser, William D; Lacaze-Masmonteil, Thierry; Lavoie, Pascal; Mâsse, Benoît R; Nuyt, Anne Monique
Keywords: Breastfeeding; Bronchopulmonary Dysplasia; Child Neurodevelopment; Neonatal Nutrition; Omega-3 Fatty Acids; Perinatality; Prematurity; Randomized Controlled Trial
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.